Identification of Substrate-specific Allosteric Fingerprints in Matrix Metalloprotease-1 on Amyloid-beta Peptide Aggregates and Drug Screening With Single Molecule Insights
Open accessAbstract
Amyloid-beta peptide (Aβ) is the primary component of water-insoluble extracellular plaques, one of the critical hallmarks of Alzheimer's disease (AD). Matrix metalloproteases (MMPs) are broad-spectrum proteases with diverse functions, including interactions with Aβ. Here we report single molecule measurements of MMP1 dynamics on Aβ-induced aggregates by calculating Forster Resonance Energy Transfer (FRET) between two dyes attached to the catalytic and hemopexin domains. We show that the two domains of MMP1 prefer closed conformations on Aβ-induced aggregates, in contrast to the preference for open conformations on collagen fibril, fibrin, and alpha-synuclein aggregates. We approximated the MMP1 dynamics by a two-state Poisson process and determined the kinetic rates of interconversion between the two states from histograms and correlations of FRET values. We performed molecular docking of MMP1 with Aβ using ClusPro, simulated MMP1 dynamics using different docking poses, and matched the experimental and simulated interdomain dynamics to identify an appropriate pose. We used simulations to create a two-dimensional map of correlations between every pair of MMP1 residues, which shows allosteric communications between the two MMP1 domains. We calculated a Gray Level Co-occurrence Matrix from the two-dimensional map of correlations and quantified MMP1 fluctuations by Shannon entropy. We identified the allosteric residues in the hemopexin domain by identifying residues having strong correlations with the catalytic motif residues. We identified that the residues I364, G369, P409, G410, and D418 in MMP1 have Aβ-specific allosteric correlations with the MMP1 catalytic motif by comparing residues for free and Aβ-bound MMP1. We used these Aβ-specific allosteric residues to select small molecule ligands after the virtual screening of molecules against Aβ-bound MMP1. Molecular understanding of interactions between MMP1 and Aβ-induced aggregates and identification of substrate-specific allosteric residues may enable controlling MMP1 function selectively on Aβ.
AI snapshot
Written from the paper’s full text.
TL;DR
Single-molecule FRET and simulations show that MMP1 prefers closed interdomain conformations on Aβ-induced aggregates, unlike its open preference on collagen, fibrin, and alpha-synuclein aggregates. The study identifies Aβ-specific allosteric residues and uses them to guide virtual screening of FDA-approved compounds.
Key findings
- On Aβ-induced aggregates, active MMP1 without ligand has two states S1=0.47 and S2=0.52, with autocorrelation decay rate 0.02 s⁻¹; by comparison, collagen gives S1=0.44/S2=0.55 and 0.13 s⁻¹, fibrin S1=0.42/S2=0.51 and 0.08 s⁻¹, and alpha-synuclein aggregates S1=0.46/S2=0.52 and 0.08 s⁻¹. Tetracycline shifts both active and inactive MMP1 toward closed conformations.
- Docking and MD simulations suggest pose 3 is functionally relevant, with MMP1 binding between Aβ residues V12 and L17; active MMP1 prefers closed conformations more than inactive MMP1, and catalytic pocket opening positively correlates with interdomain separation for active MMP1 in poses 1 and 3.
- Allosteric analysis identified residues I364, G369, P409, G410, and D418 in the hemopexin domain as having Aβ-specific correlations >0.8 with the catalytic motif HELGHSLGLSH, common across three repeats of Aβ-bound active MMP1.
- Virtual screening of ~9000 FDA-approved ZINC15 compounds yielded ~600 drugs with at least 10% difference between top two binding modes, then 23 lead molecules binding within ±2 residues of the Aβ-specific allosteric residues; Trosec had the highest predicted affinity and bound near K362.
Methods
- smFRET with TIRF microscopy: active E219 and inactive Q219 MMP1 mutants with S142C/S366C labeled with Alexa555/Alexa647, measured on a thin layer of Aβ-induced aggregates; FRET was calculated as I_A/(I_A+I_D), and histograms/autocorrelations were fit to a two-state Poisson process.
- All-atom MD: ClusPro docking of MMP1 (PDB 4AUO) and Aβ (PDB 1IYT) produced three top poses; Gromacs 2021.2 with Amber99 and SPC/E water, 20 ns production runs, 2 fs steps, sampled every 5 ps, three repeats at 22 °C or 37 °C; interdomain S142-S366 and catalytic pocket N171-T230 distances, residue-pair correlation matrices, and GLCM Shannon entropy were analyzed.
- Virtual screening: AutoDock Vina against free MMP1 and three Aβ-bound poses, using ~9000 FDA-approved molecules from ZINC15; compounds were selected by ≥10% affinity difference between top two modes and proximity to Aβ-specific allosteric residues.
Limitations
- Stated: experiments were performed on Aβ aggregates while simulations used Aβ monomers; no crystal structure exists for Aβ-bound MMP1, so binding poses were predicted; computational binding energy may not be the best indicator of appropriate docking poses; more studies are needed to explain substrate-dependent open/closed preferences; not all identified allosteric residues have associated lead molecules.
- Evident from the text: MD simulations were short (20 ns) with three repeats and only three top docking poses; virtual screening used exhaustiveness 10 for quicker screening, and no experimental validation of the lead molecules is reported.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
0 of 14 cited sources checked · 0 supported · 0 flagged
- Findingown data
In the presence of tetracycline, both active and inactive MMP1 prefer closed conformations more on Aβ-induced aggregates.
“In the presence of tetracycline, a known MMP inhibitor, both active and inactive MMP1 prefer the closed conformations more (Figure 1F).”
Quote in the paperSubstantial claim - Findingown data
Residues I364, G369, P409, G410, and D418 in MMP1 have Aβ-specific allosteric correlations with the MMP1 catalytic motif.
“Comparing the residues between Aβ-bound active MMP1 with free active MMP1, we identi ed that the residues I364, G369, P409, G410, and D418 are common among the three repeats of Aβ-bound active MMP1 simulations and have exclusive correlations for Aβ-bound active MMP1.”
- Also stated in: § Abstract · plain
“We identi ed that the residues I364, G369, P409, G410, and D418 in MMP1 have Aβ-speci c allosteric correlations with the MMP1 catalytic motif by comparing residues for free and Aβ-bound MMP1.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · plain
- Findingown data
The two states are S1=0.47 and S2=0.52 on Aβ-induced aggregates for active MMP1 without ligand.
“The two states are S1=0.47 and S2=0.52 on Aβ-induced aggregates for active MMP1 without ligand (Table S1).”
Quote in the paperSubstantial claim - Findingown data
Further selection identified 23 lead molecules binding within ±2 residues around the Aβ-specific allosteric residues (I364, G369, P409, G410, and D418).
“Then, we further selected drugs by identifying drugs binding within ±2 residues around the Aβ-speci c allosteric residues (I364, G369, P409, G410, and D418) to only 23 lead molecules.”
Quote in the paperSubstantial claim - Findingown data
Virtual screening of approximately 9000 FDA-approved drugs selected about 600 drugs with at least 10% difference between binding affinities at the top two binding modes.
“To this end, we screened ~9000 FDA-approved drugs (see methods) from the ZINC15 database and selected compounds for which the difference between the binding a nities at the top two binding modes is at least 10% because we want to nd drugs that bind preferably to a speci c site on MMP1.With a 10% difference, we found ~600 drugs out of ~9000 starting drugs.”
Quote in the paperSubstantial claim
- Findingown data
The correlations between catalytic pocket opening and interdomain separation are positive for active MMP1 and negative for inactive MMP1 for pose 1 and pose 3.
“The correlations between the catalytic pocket opening and interdomain separation are positive for active MMP1 and negative for inactive MMP1 for pose 1 and pose 3 (Figures 3J and 3L).”
Quote in the paperSubstantial claim - Findingown data
The configuration at the MMP1 catalytic site differs considerably between active and inactive MMP1.
“The comparison reveals that the con guration at the MMP1 catalytic site differs considerably between active and inactive MMP1.”
Quote in the paperSubstantial claim - Findingown data
For active MMP1 without ligand, MMP1 prefers closed conformations on Aβ-induced aggregates.
“Area-normalized histograms of FRET values without ligands (Figure 1E) suggest that MMP1 prefers closed conformation on Aβ aggregates.”
- Also stated in: § Abstract · boosted
“We show that the two domains of MMP1 prefer closed conformations on Aβ-induced aggregates, in contrast to the preference for open conformations on collagen bril, brin, and alpha-synuclein aggregates.”
Quote in the paperSubstantial claim - Also stated in: § Abstract · boosted
- Findingcitation
The presence of noise can convert a power law correlation into an exponential correlation.
“In other words, the presence of noise can convert a power law correlation into an exponential correlation, similar to the conversion of a Lorentzian line shape into a Gaussian line shape by noise (36).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [36]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Findingown data
The correlation decay rate is 0.02 s -1 on Aβ-induced aggregates for active MMP1 without ligand.
“The correlation decay rate is 0.02 s -1 on Aβ-induced aggregates for active MMP1 without ligand (Table S1).”
Quote in the paperSubstantial claim - Findingown data
Allosteric residues reduce the number of lead molecules significantly.
“Allosteric residues reduce the number of lead molecules signi cantly.”
Quote in the paperSubstantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
- Findingown data
Power law does not fit autocorrelations of simulated FRET values with noise for active and inactive MMP1.
“Power law does not t autocorrelations (active: dashed red line; inactive: solid green line).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The two-state model adequately describes MMP1 dynamics on Aβ.
- Findingown data
Shannon entropy calculated from correlation plots for active MMP1 is S=3.06±0.04 (mean±SEM).
“Shannon entropy calculated from correlation plots for active (S=3.06±0.04,mean±SEM) and inactive (S=3.03±0.03,mean±SEM).”
Quote in the paperSubstantial claim - Findingnone given
Not all identified allosteric residues have associated lead molecules.
“Also, not all identi ed allosteric residues have associated lead molecules.”
Quote in the paperNot a substantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
- Findingown data
Compounds bind to Aβ-specific allosteric residues in MMP1 in pose 3.
“Compounds that bind to Aβ-speci c allosteric residues in MMP1 in pose 3.”
Quote in the paperSubstantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
- Findingown data
Shannon entropy calculated from correlation plots for inactive MMP1 is S=3.03±0.03 (mean±SEM).
“Shannon entropy calculated from correlation plots for active (S=3.06±0.04,mean±SEM) and inactive (S=3.03±0.03,mean±SEM).”
Quote in the paperNot a substantial claim - Findingown data
Trosec bound to Ab-bound MMP1 in pose 3.
“Trosec bound to Ab-bound MMP1 in pose 3.”
Quote in the paperNot a substantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
- Findingown data
We identified molecules binding near the Aβ-specific allosteric residues in MMP1.
“We identi ed molecules binding near the Aβ-speci c allosteric residues in MMP1.”
Quote in the paperSubstantial claim - Findingnone given
Lead molecules depend on whether MMP1 is free or bound to Aβ.
“Lead molecules depend on whether MMP1 is free or bound to Aβ.”
Quote in the paperSubstantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
- Interpretationown data
A positive correlation between catalytic pocket opening and interdomain separation suggests that pose 3 may be a functional binding pose.
“A positive correlation between the distances further suggests that pose 3 may be a functional binding pose.”
Quote in the paperSubstantial claim - Interpretationown data
The integrative approach combining experiments and simulations enables identification of substrate-dependent allostery at the single molecule level.
“The integrative approach combining experiments and simulations enables the identi cation of substrate-dependent allostery at the single molecule level.”
Quote in the paperSubstantial claim - Interpretationown data
Substrate-specific allosteric residues may enable controlling one MMP1 function without affecting the other functions.
“Identifying substrate-speci c allosteric residues is signi cant because it may enable controlling one MMP1 function without affecting the other functions.”
- Also stated in: § Introduction · hedged
“Our method of identifying substrate-speci c and functionally-relevant allosteric residues may enable modulating one MMP1 function without affecting the other functions, thereby targeting MMPs with fewer side effects.”
Quote in the paperSubstantial claim - Also stated in: § Introduction · hedged
- Premiseown data
Labeling MMP1 with Alexa555 and Alexa647 does not affect MMP1 activity.
“Previously, we showed that labeling does not affect the activity of MMP1.”
Quote in the paperSubstantial claim - Interpretationown data
MMP1 binds between residues V12 and L17 of Aβ (pose 3).
“A comparison between experiments and simulations suggest that MMP1 binds between residues V12 and L17 of Aβ (pose 3).”
Quote in the paperSubstantial claim - Interpretationcitation
The cleavage sites of MT-MMP1 on Aβ are located around the middle of Aβ, closer to the MMP1 catalytic site in pose 3.
“These cleavage sites are located around the middle of Aβ, closer to the MMP1 catalytic site in pose 3 (Figure 3C).”
Quote in the paperSubstantial claim - Interpretationown data
Pose 3 is a relevant binding pose between MMP1 and Aβ.
“Based on this match between experiments and simulations, we considered pose 3 a relevant binding pose between MMP1 and Aβ for further analysis.”
- Also stated in: § MMP1 dynamics depend on the MMP1-Aβ binding pose. Since crystal structures of Aβ-bound MMP1 do · hedged
“In summary, a combination of known cleavage sites, single molecule measurements of dynamics, and all-atom simulations suggest that pose 3 may be a functionally relevant binding pose.”
Quote in the paperSubstantial claim - Also stated in: § MMP1 dynamics depend on the MMP1-Aβ binding pose. Since crystal structures of Aβ-bound MMP1 do · hedged
- Interpretationown data
Catalytic domain residues (F100-Y260) have strong correlations with hemopexin domain residues (D279-C466), suggesting allosteric communications in MMP1.
“The catalytic domain residues (F100-Y260) have strong correlations with the hemopexin domain residues (D279-C466), suggesting allosteric communications in MMP1 (Figures 4B-C).”
Quote in the paperSubstantial claim - Interpretationown data
Aβ has a unique signature or fingerprint on MMP1 at the catalytic and distant allosteric sites.
“As a proof of principle, we wanted to check if Aβ-speci c allosteric residues may help the selection of drugs because Aβ has its unique signature or”
Quote in the paperSubstantial claim - Premisecitation
MMP1 prefers open conformations on collagen fibrils, fibrin, and alpha-synuclein aggregates.
“This is in contrast to the MMP1's preference for the open conformations on collagen, brin, and alpha-synuclein.”
- Also stated in: § Conclusions · plain
“In contrast, we previously reported that MMP1 prefers open conformations on collagen (34), brin (35), and alpha-synuclein aggregates.”
Quote in the paperSubstantial claim0 of 2 sources checked- cites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [35]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Also stated in: § Conclusions · plain
- Interpretationreasoning
For Aβ, not restraining the Aβ backbone for agreement between simulations and experiments suggests a lack of strain in Aβ aggregates.
“For Aβ, we did not have to restrain the Aβ backbone for agreement between simulations and experiments, suggesting a lack of strain in Aβ aggregates.”
Quote in the paperSubstantial claim - Study design and conductown data
The two-state Poisson process description of MMP1 dynamics on Aβ-induced aggregates is valid, including in the presence of tetracycline.
“We con rmed the validity of the two-state Poisson process approach to MMP1 dynamics by simulating and analyzing smFRET trajectories using experimentally determined S1, S2, k1, k2, and noise (widths of the histograms).”
- Also stated in: § Results And Discussion · plain
“Tetracycline changes the conformational distributions of MMP1 and associated interconversion rates, but the two-state description remains valid (Table S1).”
Quote in the paperSubstantial claim - Also stated in: § Results And Discussion · plain
- Premisecitation
Computational binding energy may not be the best indicator of appropriate docking poses.
“Since the computational binding energy may not be the best indicator of appropriate docking poses (39), we leveraged known cleavage sites for a similar MMP.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [39]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationown data
Screening a more significant number of compounds may identify drugs with an exclusive binding preference for an allosteric site on MMP1, potentially reducing off-target effects.
“These results suggest that we may be able to identify drugs with an exclusive binding preference for an allosteric site on MMP1 by screening a more signi cant number of compounds, potentially reducing off-target effects.”
Quote in the paperSubstantial claim - Interpretationreasoning
Substrate-specific allosteric residues or allosteric fingerprints may alter one MMP1 function without affecting its other activities using allosteric ligands.
“Since MMPs interact with and degrade many biomolecules in the human body, substrate-speci c allosteric residues or”
Quote in the paperSubstantial claim - Premisecitation
Membrane tethered MT-MMP1 cleaves Aβ and produces several fragments, including Aβ fragments with amino acids D1-H14, D1-Q15, D1-L17, V18-V36, and V12-A30.
“Membrane tethered MT-MMP1, a collagenase similar to MMP1, cleaves Aβ and produces several fragments, including Aβ fragments with amino acids D1-H14, D1-Q15, D1-L17, V18-V36, and V12-A30 (25).”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- Interpretationreasoning
The two-way feedback between experiments and simulations provides a starting point for a molecular-level understanding of MMP1-Aβ interactions.
“Nevertheless, the two-way feedback between experiments and simulations provides a starting point for a molecular-level understanding of MMP1-Aβ interactions.”
Quote in the paperSubstantial claim
- May combine two claims. 15
- Classified as probably not a substantial claim. 16
May combine two claims.
Findingown dataTrosec has the highest predicted affinity and binds to residue K362.
“Figure 6E shows how Trosec, the drug with the highest predicted a nity, binds to residue K362.”
Quote in the paperNot a substantial claimMay combine two claims.
Findingown dataVirtual screening results change upon binding Aβ and depend on the binding pose.
“We found that virtual screening results change upon binding Aβ and depend on the binding pose.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataActive MMP1 prefers closed conformations more than inactive MMP1 in simulations, in agreement with experiments.
“Figures 3D-F show the distributions of S142-S366 distance, which show that active MMP1 prefers closed conformations (high FRET) more than inactive MMP1, in agreement with experiments (Figure 1E).”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataA sum of two Gaussians fits the FRET histograms, suggesting an equilibrium of the open and closed conformations.
“A sum of two Gaussians ts the histograms, suggesting an equilibrium of the open and closed conformations.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataThe presence of noise increases the width of conformational histograms but subtly affects autocorrelations.
“The presence of noise increases the width of conformational histograms but subtly affects autocorrelations.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
Findingown dataBoth exponential and power law fit autocorrelations of simulated FRET values without noise for active and inactive MMP1.
“Both exponential and power law t autocorrelations (active: dashed red line; inactive: solid green line).”
Quote in the paperNot a substantial claim- The authors state this as an assumption: The two-state model adequately describes MMP1 dynamics on Aβ.
Classified as probably not a substantial claim.
Findingown dataSubstrate- and pose-dependent virtual screening of molecules against MMP1.
“Substrate -and pose-dependent virtual screening of molecules against MMP1.”
Quote in the paperSubstantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
Classified as probably not a substantial claim.
Findingown dataMMP1-Aβ binding pose-dependent dynamics of MMP1 at 22 °C.
“MMP1-Aβ binding pose-dependent dynamics of MMP1 at 22 °C.”
Quote in the paperSubstantial claim- Rests on an assumption: The three top-scoring ClusPro binding poses between MMP1 and Aβ represent the biologically relevant binding modes.
Classified as probably not a substantial claim.
Findingown dataBinding affinities of lead compounds and closest MMP1 residues for Aβ-bound MMP1 in poses 1, 2, and 3.
“Binding a nities of lead compounds and closest MMP1 residues for Aβ-bound MMP1 in (A) pose 1, (B) pose 2, and (C) pose 3.”
Quote in the paperSubstantial claim- Rests on an assumption: AutoDock Vina docking scores reflect true binding affinities.
Classified as probably not a substantial claim. May combine two claims.
Findingnone givenConformational changes of the MMP1 catalytic motif and identification of Aβ-specific allosteric residues at 37 °C for pose 3.
“Conformational changes of the MMP1 catalytic motif and identi cation of Aβ-speci c allosteric residues at 37 °C for pose 3.”
Quote in the paperSubstantial claim- Rests on an assumption: The three top-scoring ClusPro binding poses between MMP1 and Aβ represent the biologically relevant binding modes.
Classified as probably not a substantial claim.
Findingown dataInterdomain dynamics of MMP1 on Aβ-induced aggregates at 22 oC with 100 ms time resolution.
“Interdomain dynamics of MMP1 on Aβ-induced aggregates at 22 ºC with 100 ms time resolution.”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Findingown dataQuantification of MMP1 allostery on Aβ at 22 °C for pose 3.
“Quanti cation of MMP1 allostery on Aβ at 22 °C for pose 3.”
Quote in the paperSubstantial claim- Rests on an assumption: The three top-scoring ClusPro binding poses between MMP1 and Aβ represent the biologically relevant binding modes.
May combine two claims.
Findingown dataThe decay rate of autocorrelations does not change as the noise level varies, and an exponential fit recovers the underlying decay rate with and without noise.
“The decay rate of autocorrelations does not change as the noise level varies, and an exponential t recovers the underlying decay rate with and without noise.”
Quote in the paperSubstantial claimMay combine two claims.
Findingown dataIn the absence of noise, both power-law and exponential distributions fit the autocorrelations; with noise, only an exponential distribution fits.
“In the absence of noise, both powerlaw and exponential distributions t the autocorrelations (Figure 2F).However, with noise, the y-intercept of the autocorrelations decreases, and only an exponential distribution ts the autocorrelations.”
Quote in the paperSubstantial claimMay combine two claims.
PremisecitationSimulations of MMP1 dynamics on a collagen monomer agreed with experiments on collagen fibril when the collagen backbone was restrained, suggesting strains in collagen monomers inside collagen fibrils.
“We took a similar approach for collagen and found that simulations of MMP1 dynamics on a collagen monomer agreed with experiments on collagen bril when the collagen backbone was restrained (34), suggesting the presence of strains in collagen monomers inside collagen brils.”
Quote in the paperSubstantial claim0 of 1 sources checked- cites [34]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationThe catalytic domain sequence across the MMP family is very similar, but the hemopexin domain sequence varies, suggesting a role of communications in substrate diversity and specificity.
“The catalytic domain sequence across the MMP family is very similar, but the hemopexin domain sequence varies (31,32), suggesting a role of communications in substrate diversity and speci city (12,33).”
Quote in the paperNot a substantial claim0 of 4 sources checked- cites [31]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [32]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [12]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [33]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
May combine two claims.
Study design and conductown dataThe two-state Poisson process recovers underlying parameters reasonably well despite noise; histograms and autocorrelations recover the underlying parameters.
“Underlying noise can obscure the individual states (Figures 2A-B), but histograms (Figures 2C and 2E) and autocorrelations (Figures 2D and 2F) still recovers the underlying parameters reasonably well (Table S2).”
Quote in the paperSubstantial claimClassified as probably not a substantial claim.
Study design and conductnone givenInactive MMP1 acts as a control to distinguish the effects of enzymatic activity from the effects of the microenvironment and photophysical properties of the dyes.
“Inactive MMP1 acts as a control to distinguish the effects of enzymatic activity from the effects of the microenvironment and photophysical properties of the dyes.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenWe repeated simulations three times for each condition.
“We repeated simulations three times for each condition.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisecitationPDB ID 4AUO starts with FVLTEG and has 366 residues.
“For reference, PDB ID 4AUO starts with FVLTEG (47) and has 366 residues.”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.
PremisereasoningE219 is the same residue as E200, which differs due to the first amino acid used for counting.
“E219 (40) is the same residue as E200 (47), which differs due to the rst amino acid used for counting.”
Quote in the paperNot a substantial claim0 of 2 sources checked- cites [40]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
- cites [47]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
Probably not a substantial claim: may not pass S3 (load-bearing), S4 (based).
Premisenone givenTetracycline holds the two MMP1 domains via hydrogen bonds, facilitating the preference for closed conformations.
“Previously, we argued that tetracycline holds the two MMP1 domains via hydrogen bonds, facilitating the preference for closed conformations.”
Quote in the paperNot a substantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
Study design and conductnone givenThe error bars in Figures 3D-I represent the standard deviations of three repeats of simulations for each condition.
“The error bars in Figures 3D-I represent the standard deviations of three repeats of simulations for each condition.”
Quote in the paperNot a substantial claimMay combine two claims.
Interpretationown dataSubstrate- and pose-dependent screening results suggest that the substrate, the binding pose, and the ligand-binding site should be considered when targeting MMP1.
“Substrateand pose-dependent screening results suggest that we need to consider the substrate, the binding pose, and the ligand-binding site targeting MMP1.”
Quote in the paperSubstantial claimProbably not a substantial claim: may not pass S3 (load-bearing).
PremisereasoningCounting from MHSFPP, the FVLTEG numbers are 100, 101, 102, 103, 104, and 106.
“We counted from MHSFPP, and as such, FVLTEG numbers are 100, 101, 102, 103, 104, and 106.”
Quote in the paperNot a substantial claim- Rests on an assumption: Full-length MMP1 has 469 residues.
- Rests on an assumption: The first six amino acids of full-length MMP1 are MHSFPP, and the last six are FNCRKN.
Probably not a substantial claim: may not pass S3 (load-bearing).
PremisecitationMT-MMP1 cleaves Aβ between H14 and Q15.
“MT-MMP1 cleaves Aβ between H14 and Q15 (25).”
Quote in the paperNot a substantial claim0 of 1 sources checked- cites [25]
Couldn’t be matched to a paper in Crossref, so it can’t be checked.
The paper relies on this without support.
Simulations on Aβ monomers can inform the behavior of MMP1 on Aβ aggregates.
“However, there are some caveats because we performed experiments on Aβ aggregates and performed simulations on Aβ monomers.”
“There are caveats because we performed simulations on Aβ monomer and experiments on aggregates.”
The paper relies on this without support.
The cleavage sites of MT-MMP1 are relevant to the MMP1-Aβ binding pose.
“Since the computational binding energy may not be the best indicator of appropriate docking poses (39), we leveraged known cleavage sites for a similar MMP.”
The paper relies on this without support.
The three best scoring docking poses include the functionally relevant MMP1-Aβ binding pose.
“To mimic experiments, we selected the three best scoring poses (Figures 3A-C) and performed all-atom MD simulations at 22 °C for active and inactive MMP1.”
The paper relies on this without support.
Full-length MMP1 has 469 residues.
“Full-length MMP1 has 469 residues.”
The paper relies on this without support.
The first six amino acids of full-length MMP1 are MHSFPP, and the last six are FNCRKN.
“The rst six amino acids are MHSFPP, and the last six amino acids are FNCRKN.”
The paper relies on this without support.
The catalytic triad HEL residues are H218, E219, and L220.
“The catalytic triad HEL residues are H218, E219, and L220.”
The paper relies on this without support.
The three top-scoring ClusPro binding poses between MMP1 and Aβ represent the biologically relevant binding modes.
“We selected the three best scoring binding poses between MMP1 and Aβ.”
The authors state this as an assumption.
The two-state model adequately describes MMP1 dynamics on Aβ.
“Stochastic simulation of MMP1 dynamics on Aβ as a two-state system.”
The paper relies on this without support.
AutoDock Vina docking scores reflect true binding affinities.
“We adjusted the box size to enclose the whole MMP1 to identify each compound's binding locations and a nities using an exhaustiveness of 10 for quicker screening.”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Two decay rates reported for the same MMP1 condition
MinorThe paper reports both 0.02 s−1 and 0.08 s−1 for the correlation decay rate of active MMP1 without ligand on Aβ aggregates. The conflicting values affect its comparison of dynamics across substrates.
“The correlation decay rate is 0.02 s -1 on Aβ-induced aggregates for active MMP1 without ligand (Table S1).”
“the decay rates are 0.13 s -1 on collagen (34), 0.08 s -1 on brin (35), and 0.08 s -1 on Aβ aggregates for active MMP1 without ligand.”
Cites
UCSF Chimera—A visualization system for exploratory research and analysis
Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004) · Journal of Computational Chemistry · doi:10.1002/jcc.20084 · Cited by 45,260 · see citing works
Abraham, M. J., Murtola, T., Schulz, R., Páll, S., Smith, J. C., Hess, B., & Lindahl, E. (2015) · SoftwareX · doi:10.1016/j.softx.2015.06.001 · Cited by 27,190 · see citing works
Structure and Dynamics of the TIP3P, SPC, and SPC/E Water Models at 298 K
Mark, P., & Nilsson, L. (2001) · The Journal of Physical Chemistry A · doi:10.1021/jp003020w · Cited by 4,756 · see citing works
Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid β-peptide
Haass, C., & Selkoe, D. J. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2101 · Cited by 4,744 · see citing works
The ClusPro web server for protein–protein docking
Kozakov, D., Hall, D. R., Xia, B., Porter, K. A., Padhorny, D., Yueh, C., Beglov, D., & Vajda, S. (2017) · Nature Protocols · doi:10.1038/nprot.2016.169 · Cited by 3,297 · see citing works
The Amyloid Beta Peptide: A Chemist’s Perspective. Role in Alzheimer’s and Fibrillization
Hamley, I. W. (2012) · Chemical Reviews · doi:10.1021/cr3000994 · Cited by 881 · see citing works
ClusPro: a fully automated algorithm for protein-protein docking
Comeau, S. R., GATCHELL, D. W., Vajda, S., & Camacho, C. J. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh354 · Cited by 826 · see citing works
A Single-Molecule Study of RNA Catalysis and Folding
Zhuang, X., Bartley, L., Babcock, H. P., Russell, R., Ha, T., Herschlag, D., & Chu, S. (2000) · Science · doi:10.1126/science.288.5473.2048 · Cited by 732 · see citing works
Solution structure of the Alzheimer amyloid β‐peptide (1–42) in an apolar microenvironment
Crescenzi, O., Tomaselli, S., Guerrini, R., Salvadori, S., D’Ursi, A. M., Temussi, P. A., & Picone, D. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03271.x · Cited by 692 · see citing works
Rodrı́guez, D., Morrison, C., & Overall, C. M. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.09.015 · Cited by 560 · see citing works
Determination of the Gaussian and Lorentzian content of experimental line shapes
Wertheim, G. K., Butler, M. A., West, K. W., & Buchanan, D. N. E. (1974) · Review of Scientific Instruments · doi:10.1063/1.1686503 · Cited by 540 · see citing works
Lemkul, J. A. (2018) · Living Journal of Computational Molecular Science · doi:10.33011/livecoms.1.1.5068 · Cited by 525 · see citing works
Matrix metalloproteinases: Fold and function of their catalytic domains
Tallant, C., Marrero, A., & Gomis‐Rüth, F. X. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.04.003 · Cited by 467 · see citing works
Proteases and Proteolysis in Alzheimer Disease: A Multifactorial View on the Disease Process
De Strooper, B. (2010) · Physiological Reviews · doi:10.1152/physrev.00023.2009 · Cited by 455 · see citing works
Li, Z., Chalazonitis, A., Huang, Y.-Y., Mann, J. J., Margolis, K. G., Yang, Q. M., Kim, D. O., Cote, F., Mallet, J., & Gershon, M. D. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.6684-10.2011 · Cited by 403 · see citing works
Matrix Metalloproteinase-9 Degrades Amyloid-β Fibrils in Vitro and Compact Plaques in Situ
Yan, P., Hu, X., Song, H., Yin, K., Bateman, R. J., Cirrito, J. R., Xiao, Q., Hsu, F. F., Turk, J. W., Xu, J., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602440200 · Cited by 380 · see citing works
Proteolytic Degradation of Amyloid -Protein
Saido, T., & Leissring, M. A. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006379 · Cited by 368 · see citing works
Backstrom, J. R., Lim, G. P., Cullen, M. J., & Tökés, Z. A. (1996) · The Journal of Neuroscience · doi:10.1523/jneurosci.16-24-07910.1996 · Cited by 331 · see citing works
Field, M. J., Albe, M., Bret, C., Martin, F. P.-D., & Thomas, A. M. (2000) · Journal of Computational Chemistry · doi:10.1002/1096-987x(200009)21:12 · Cited by 303 · see citing works
Cauwe, B., & Opdenakker, G. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.501783 · Cited by 296 · see citing works
Matrix metalloproteinase proteomics: substrates, targets, and therapy
Morrison, C., Butler, G. S., Rodrı́guez, D., & Overall, C. M. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.06.006 · Cited by 266 · see citing works
Matrix metalloproteinases and their endogenous inhibitors in neuronal physiology of the adult brain
Dzwonek, J., Rylski, M., & Kaczmarek, L. (2004) · FEBS Letters · doi:10.1016/j.febslet.2004.03.070 · Cited by 256 · see citing works
Zucker, S., Hymowitz, M., Conner, C. E., Zarrabi, M. H., Hurewitz, A. N., Matrisian, L. M., Boyd, D. D., Nicolson, G. L., & Montana, S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07687.x · Cited by 236 · see citing works
Extracellular matrix degradation by metalloproteinases and central nervous system diseases
Lukes, A., Mun-Bryce, S., Lukes, M., & Rosenberg, G. A. (1999) · Molecular Neurobiology · doi:10.1007/bf02821717 · Cited by 230 · see citing works
Structural insights into triple-helical collagen cleavage by matrix metalloproteinase 1
Manka, S. W., Carafoli, F., Visse, R., Bihan, D. G., Raynal, N., Farndale, R. W., Murphy, G., Enghild, J. J., Hohenester, E., & Nagase, H. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1204991109 · Cited by 219 · see citing works
Eckhard, U., Huesgen, P. F., Schilling, O., Bellac, C. L., Butler, G. S., Cox, J. H., Dufour, A., Goebeler, V., Kappelhoff, R., Keller, U. A. D., et al. (2015) · Matrix Biology · doi:10.1016/j.matbio.2015.09.003 · Cited by 208 · see citing works
Amyloidosis and Alzheimer’s disease
Ghiso, J. A., & Frangione, B. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00149-7 · Cited by 189 · see citing works
Arnold, B. C. (2015) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat01100.pub2 · Cited by 186 · see citing works
New intracellular activities of matrix metalloproteinases shine in the moonlight
Jobin, P. G., Butler, G. S., & Overall, C. M. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2017.05.013 · Cited by 184 · see citing works
Chemically modified tetracyclines as inhibitors of matrix metalloproteinases
Acharya, M. R., Venitz, J., Figg, W. D., & Sparreboom, A. (2004) · Drug Resistance Updates · doi:10.1016/j.drup.2004.04.002 · Cited by 153 · see citing works
Greenwald, R. A., Golub, L. M., Ramamurthy, N. S., Chowdhury, M. H., Moak, S. A., & Sorsa, T. A. (1998) · Bone · doi:10.1016/s8756-3282(97)00221-4 · Cited by 142 · see citing works
Pryor, N. E., Moss, M. A., & Hestekin, C. N. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13033038 · Cited by 112 · see citing works
Matrix Metalloproteinases and Their Multiple Roles in Alzheimer's Disease
Wang, X.-X., Tan, M., Yu, J.-T., & Tan, L. (2014) · BioMed Research International · doi:10.1155/2014/908636 · Cited by 110 · see citing works
Sequential Amyloid-β Degradation by the Matrix Metalloproteases MMP-2 and MMP-9*
Hernández-Guillamon, M., Mawhirt, S., Blais, S., Montaner, J., Neubert, T., Rostagno, A., & Ghiso, J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.610931 · Cited by 110 · see citing works
Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease
Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 105 · see citing works
Sarkar, S. K., Marmer, B. L., Goldberg, G. I., & Neuman, K. C. (2012) · Current Biology · doi:10.1016/j.cub.2012.04.012 · Cited by 103 · see citing works
Self-citationBasis for substrate recognition and distinction by matrix metalloproteinases
Ratnikov, B. I., Cieplak, P., Gramatikoff, K., Pierce, J. D., Eroshkin, A. M., Igarashi, Y., Kazanov, M. D., Sun, Q. Y., Godzik, A., Osterman, A. L., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1406134111 · Cited by 100 · see citing works
Profiles of matrix metalloproteinases and their inhibitors in plasma of patients with dementia
Lorenzl, S., Büerger, K., Hampel, H. J., & Beal, M. F. (2007) · International Psychogeriatrics · doi:10.1017/s1041610207005790 · Cited by 96 · see citing works
Liao, M.-C., & Nostrand, W. V. V. (2010) · Biochemistry · doi:10.1021/bi901994d · Cited by 91 · see citing works
The non-antibiotic properties of tetracyclines: Clinical potential in ophthalmic disease
Federici, T. J. (2011) · Pharmacological Research · doi:10.1016/j.phrs.2011.06.013 · Cited by 77 · see citing works
Mroczko, B., Groblewska, M., & Barcikowska, M. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-130647 · Cited by 61 · see citing works
Internal strain drives spontaneous periodic buckling in collagen and regulates remodeling
Dittmore, A., Silver, J. E., Sarkar, S. K., Marmer, B. L., Goldberg, G. I., & Neuman, K. C. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1523228113 · Cited by 54 · see citing works
Self-citationThe Maze of APP Processing in Alzheimer’s Disease: Where Did We Go Wrong in Reasoning?
Chen, M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00186 · Cited by 41 · see citing works
Yanamala, N. V. K., Tirupula, K. C., & Klein‐Seetharaman, J. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-s1-s16 · Cited by 39 · see citing works
Self-citationThe maze of APP processing in Alzheimer’s disease: Where did we go wrong in reasoning?
eChen, M. (2015) · Frontiers in Cellular Neuroscience · Cited by 23 · see citing works
Allosteric Communications between Domains Modulate the Activity of Matrix Metalloprotease-1
Kumar, L., Nash, A., Harms, C., Planas-Iglesias, J., Wright, D., Klein‐Seetharaman, J., & Sarkar, S. K. (2020) · Biophysical Journal · doi:10.1016/j.bpj.2020.06.010 · Cited by 20 · see citing works
Self-citationPorter, K. N., Sarkar, S. N., Dakhlallah, D. A., Vannoy, M. E., Quintana, D. D., & Simpkins, J. W. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00092 · Cited by 17 · see citing works
Self-citationActivity-dependent interdomain dynamics of matrix metalloprotease-1 on fibrin
Kumar, L., Planas-Iglesias, J., Harms, C., Kamboj, S., Wright, D., Klein‐Seetharaman, J., & Sarkar, S. K. (2020) · Scientific Reports · doi:10.1038/s41598-020-77699-3 · Cited by 14 · see citing works
Self-citationA method of purifying alpha-synuclein in E. coli without chromatography
Kamboj, S., Harms, C., Kumar, L., Creamer, D., West, C., Klein‐Seetharaman, J., & Sarkar, S. K. (2021) · Heliyon · doi:10.1016/j.heliyon.2020.e05874 · Cited by 7 · see citing works
Self-citationMMPs in the gut: inflammation hits the matrix
SCHUPPAN, D., & HAHN, E. G. (2000) · Gut · doi:10.1136/gut.47.1.12
Arnold, B. C. (2014) · Wiley StatsRef: Statistics Reference Online · doi:10.1002/9781118445112.stat01100
Flagged first, then by citations
Research works printed but not linked: 3
- Overall, C. M. 2002. Molecular determinants of metalloproteinase substrate speci city. Molecular biotechnology 22(1):51-86.
- Czerski, J., W. Colomb, F. Cannataro, and S. Sarkar. 2018. Spectroscopic identi cation of individual uorophores using photoluminescence excitation spectra. Journal of microscopy 270(3):261-271.
- Colomb, W., J. Czerski, J. Sau, and S. Sarkar. 2017. Estimation of microscope drift using uorescent nanodiamonds as ducial markers. Journal of microscopy 266(3):298-306.
Cited by
Sorted by citations
The substrate changes matrix metalloprotease-1 dynamics, allostery, and ligand binding affinityPreprint
Harms, C., Nash, A., & Sarkar, S. K. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.02.08.637235 · Cited by 2 · see citing works
Self-citation
- Authors
- Kamboj, S., Harms, C., Wright, D., Nash, A., Klein-Seetharaman, J., & Sarkar, S. K.
- Affiliations
- Colorado School of Mines (US)
- University of Oxford (GB)
- Colorado School of Mines
- Corresponding author
- Sarkar, Susanta K.
- Venue
- Research Square
- Publisher
- Research Square Platform LLC
- Published
- 2022-01-27
- OpenAlex
- W4210800620
- Semantic Scholar
- 6c719e8b558f3b357466f600560a836a9b2dba05
- Cited by
- 1
- References
- 33
- Citations by year
- 2025: 1
- Type
- posted content
- Language
- en
- Open access
- green
- doi.org
- Locations
- Research Square (acceptedVersion, cc-by)
- Funders
- National Institute for Health and Care Research
- Oxford Health NHS Foundation Trust
- National Institutes of Health
- National Institute of General Medical Sciences (R15GM137295)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Structure and Dynamics
- Keywords
- MMP-1, amyloid-beta, Alzheimer's disease, allosteric communication, protein aggregation, hemopexin domain, catalytic domain, fluorescence resonance energy transfer, virtual screening, small-molecule ligands, Shannon entropy, protein-ligand docking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-30.
Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-30.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review